Evgenia Gourgari, MD| Pediatric Endocrinology | MedStar Health

Evgenia Gourgari, MD
Provider is directly employed by MedStar Health

4.7 out of 5 (104 reviews)

Specialties: Pediatric Endocrinology

Languages: English


About me

Dr. Evgenia Gourgari sees patients at MedStar Georgetown University Hospital, MedStar St. Mary's Hospital and MedStar Montgomery Medical Center in Olney. She is board certified in Pediatrics and Pediatric endocrinology. Call 202-295-0547 to schedule an appointment.

Conditions and procedures

Conditions I treat

  • Abnormal Glucose Metabolism
  • Addison's Disease
  • Adrenal Adenoma
  • Adrenal Atrophy
  • Adrenal Disorders
  • Adrenal Hyperplasia
  • Adrenal Mass
  • Adrenal Neoplasm
  • Adrenogenital Syndrome
  • Androgen Excess
  • Androgen Insensitivity
  • Calcium Metabolism
  • Congenital Adrenal Hyperplasia
  • Congenital Hypothyroidism
  • Cushing Syndrome
  • Delayed Puberty
  • Diabetes Insipidus
  • Diabetes Mellitus
  • Diabetic Coma
  • Diabetic Ketoacidosis
  • Disorders Of Sexual Differentiation
  • Disorders Of Water Balance
  • Ectopic Hyperparathyroidism
  • Elevated Acth
  • Elevated Growth Hormone
  • Endocrine Disorders
  • Familial Hypocalciuric Hypercalcemia
  • Feminizing Syndrome
  • Glucocorticoid Deficiency
  • Gonadal Dysgenesis
  • Grave's Disease
  • Growth Disorders
  • Growth Failure
  • Growth Hormone Abnormalities
  • Growth Hormone Deficiency
  • Gynecomastia
  • Hashimoto Thyroiditis
  • History Of Pituitary Mass
  • Hyperaldosteronism
  • Hypercalcemia
  • Hyperglycemia
  • Hyperparathyroidism
  • Hyperthyroidism
  • Hypo Thalamic Pituitary Disorder
  • Hypocalcemia
  • Hypoglycemia
  • Hypogonadism
  • Hypoparathyroidism
  • Hypopituitarism
  • Hypothyroidism
  • Insulin Resistance
  • Islet Cell Hyperplasia
  • Juvenile Diabetes
  • Low T3
  • Low T4
  • Maturity Onset Diabetes Of The Young
  • Mccune Albright Syndrome
  • Metabolic Abnormalities
  • Metabolic Disorders (INHERITED)
  • Metabolic Syndrome
  • Morbid Obesity
  • Multiple Endocrine Neoplasia
  • Multiple Endocrine Neoplasia Type 1
  • Multiple Endocrine Neoplasia Type 2
  • Multiple Endocrine Neoplasia Type 2A
  • Multiple Endocrine Neoplasia Type 2B
  • Myxedema
  • Nodular Goiter
  • Non Toxic Goiter
  • Ovarian Failure
  • Panhypopituitarism
  • Parathyroid Adenoma
  • Parathyroid Cancer
  • Parathyroid Disease
  • Parathyroid Mass
  • Pheochromocytoma
  • Pituitary Adenoma
  • Pituitary Disorders
  • Pituitary Tumor
  • Polycystic Ovary Syndrome
  • Polyglandular Autoimmune Syndrome
  • Precocious Puberty
  • Premature Adrenarche
  • Pseudohermaphroditism
  • Pseudohypoparathyroidism
  • Rickets
  • Salt Balance Disorders
  • Secondary Hyperaldosteronism
  • Testicular Dysfunction
  • Testosterone Deficiency
  • Thelarche
  • Thyroid Cancer
  • Thyroid Cyst
  • Thyroid Disorder
  • Thyroid Nodule
  • Thyroiditis
  • Thyrotoxic Exophthalmos
  • Thyrotoxicosis
  • Turner Syndrome
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Virilizing Syndrome
  • Vitamin D Deficiency
  • Weight Problem
Show All Show Less

Procedures I perform

  • Diabetes Education
  • Insulin Pump
  • Supprelin Implant
  • Thyroid Function Blood Panel
Show All button Press enter to expand Show Less

Practice locations

Distance from Change LocationEnter your Location

4200 Wisconsin Avenue Northwest
Suite 400
Washington, DC, 20016


Fax 877-680-5502

Get Directions

miles away

Fax 877-680-5502


MedStar Health accepts most major health insurance plans. If you are uncertain as to whether your individual health insurance plan is accepted at MedStar Health, please call your insurance company.

  • List of insurance plans we accept
    • United Healthcare Options (PPO) (includes Empire PPO, GEHA, Compass Rose)
    • UnitedHealthcare and AARP Medicare Complete Plans/ UHC Group Medicare Advantage Plans HMO, POS, PPO
    • Kaiser Permanente Medicare Advantage Signature and Select (aka Senior Advantage)
    • Blue Choice Advantage & Healthy Blue (HMO, POS)
    • CFBCBS Federal Employee Program (Std/Basic PPO/Blue Focus)
    • Kaiser Permanente Medicare Plus (Medicare Supplemental Plan)
    • Kaiser Permanente Signature-Added Choice
    • UnitedHealthcare Medicare Adv/Special Needs Plans
    • Kaiser Permanente Signature
    • Kaiser Virginia Premier
    • Private Health Care Systems (PHCS) (PPO)
    • Kaiser Permanente Select
    • Medicare Fee for Service
    • Kaiser Permanente Flexible Choice POS
    • Kaiser MD Medicaid MCO
    • UHC Community Plan of MD
    • Kaiser PermanenteSelect-Added Choice
    • Aetna Innovations: HMO & EPO Plus
    • Select HMO/HealthFund/Health Network
    • Aetna HMO
    • Open POS II
    • Innovation Health: Open POS Plus
    • Choice POS & Choice POS II
    • Aetna Managed Choice Open Access (POS)
    • Open EPO Plus
    • Opoen HMO Option
    • Open HMO
    • Innovation Health: POS
    • Aetna HMO-Open Access/Select OA/HealthFund/Health Network Option OA
    • Innovation Health: Open Network Only Plus
    • Aetna Elect Choice/ Open Access (POS)
    • Innovation Health: POS Plus
    • Aetna Managed Choice (POS)
    • Innovation Health: PPO
    • Aetna Open Choice (PPO)
    • Innovation Health: Indemnity
    • Aetna Traditional Choice (PPO)
    • BlueChoice Open Access
    • CFBCBS Blue Choice Opt Out Open Access
    • HealthyBlue PPO
    • CFBSBC Blue Preferred PPO
    • Choice Fund PPO
    • PPO and PPO Plus
    • POS OA & OA Plus
    • Network OA
    • CIGNA HMO Open Access (OA)
    • United Healthcare Choice
    • Tricare Prime
    • CFBCBS BlueChoice HMO
    • Coventry Health Care of Virginia
    • Aetna Student Health Insurance
    • Aetna Quality Point of Service (POS)
    • M.D. IPA Preferred (POS)
    • MedStar Family Choice - Maryland Health Choice
    • United Healthcare Select Plus (POS)
    • Tricare for Life (Medicare Supplemental Plan)
    • CIGNA POS/Network POS
    • CIGNA Indemnity
    • MedStar Select (MedStar Associates' Plan)
    • Great-West Healthcare POS/CIGNA
    • United Student Resources
    • United Healthcare Select HMO - EPO/NPP
    • First Health PPO
    • Optimum Choice Preferred (POS) & OCI Direct (HMO)
    • Coventry of Delaware HMO/PPO
    • CFBCBS Blue Choice Opt Out Plus Open Access (POS)
    • CFBCBS Maryland Point of Service Plan (MPOS)
    • Mamsi Life & Health (Indem./PPO)
    • M.D. IPA (HMO)
    • Aetna Elect Choice/ EPO (Aetna Health Fund) Innovation Health: Network Only Plus
    • CIGNA HMO & Network (HMO)
    • Coventry Health Care National Network PPO
    • Aetna Worker's Compensation Network
    • CFBCBS (NCA) Indemnity
    • Aetna Medicare Advantage HMO & PPO Plans
    • United Healthcare Choice Plus
    • CFBCBS Maryland Indemnity or PPO


Board Certification: American Board of Pediatrics, Pediatrics

Board Certification: American Board of Pediatrics, Pediatric Endocrinology

Fellowship Program: National Institute of Health (2013)

Residency Program: Miami Childrens Hospital (2010)

Medical School: Aristotle Medical School (2002)


  • 2019: Most Outstanding Scientific Abstract Award, Medstar Health-Georgetown University Research Symposium
  • 2019: Oral presentation for the abstract “Effect of metformin on HDL proteome in youth with T1DM”, PAS conference 2019, Baltimore, MD
  • 2018: Oral presentation for the abstract “Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes”, ACTS conference 2018, Washington DC
  • 2017: Oral presentation for the abstract “Youth with type 1 diabetes have atherogenic lipoprotein particles which correlate with low insulin sensitivity”, ACTS conference 2017, Washington DC
  • 2015: Scholarship Award to attend the GHUCCTS Master Program of Science in Clinical and
  • Translational Research.
  • 2013: Special acknowledgment at the Presidential Poster Reception at Pediatric Endocrine Society Meeting “Catch up growth in pediatric patients after successful treatment of Cushings syndrome due to adrenal or pituitary tumor”.
  • 2012: The Endocrine Society travel award at ENDO
  • 2012: Outstanding Abstract Award Winner at ENDO: "A novel method for metabolic classification of polycystic ovary syndrome".
  • 2012: Presidential Poster Competition Award at ENDO 2012: “A novel method for metabolic classification of polycystic ovary syndrome".
  • 2012: NICHD Fellows Intramural Grants Supplement (FIGS) Award

News and publications

  1. Flokas ME, Zeymo A, Mete M , Anhalt H, Rother KI, Gourgari E. Overweight and obese children with optimal control in the T1D Exchange Registry: How are they different from lean children with optimal control?: A cross-sectional registry analysis, Journal of Diabetes and its complications, in press January 2020
  2. Gourgari, E., Stafford, J. M., D'Agostino, R., Jr., Dolan, L. M., Lawrence, J. M., Mottl, A., . . . Dabelea, D. (2019). Association of metformin and statin medications with surrogate measures of cardiovascular disease in youth with type 1 diabetes: the SEARCH for diabetes in youth study. Ann Pediatr Endocrinol Metab, 24(3), 187-194. doi:10.6065/apem.2019.24.3.187
  3. Miller, B. S., Spencer, S. P., Geffner, M. E., Gourgari, E., Lahoti, A., Kamboj, M. K., Sarafoglou, K. (2020). Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J Investig Med, 68(1), 16-25. doi:10.1136/jim-2019-000999
  4. Gourgari E, Junfeng Ma, Martin P. Playford, Nehal N. Mehta, Radoslav Goldman, Alan T. Remaley , Scott M. Gordon, Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study. Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.
  5. Dey AK, Groenendyk J, Mehta NN, Gourgari E. The effect of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists on cardiovascular disease in patients with type 2 diabetes. Clin Cardiol. 2019 Jan 12. doi: 10.1002/clc.23152. [Epub ahead of print] Review’
  6. Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN. Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study. Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0.
  7. Kahkoska AR, Shay CM, Couch SC, Crandell J, Dabelea D, Gourgari E, Lawrence JM, Liese AD, Pihoker C, Reboussin BA et al: Sociodemographic associations of longitudinal adiposity in youth with type 1 diabetes. Pediatric diabetes 2018, 19(8):1429-1440.
  8. Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, Kowalski AJ, Madden P, McAuliffe-Fogarty AH, McElwee-Malloy M et al: Standardizing Clinically Meaningful Outcome Measures Beyond HbA1c for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes care 2017, 40(12):1622-1630.
  9. Gourgari E, Dabelea D, Rother K: Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events? Current diabetes reports 2017, 17(12):134.
  10. Gourgari E, Wilhelm EE, Hassanzadeh H, Aroda VR, Shoulson I: A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data. Journal of diabetes and its complications 2017, 31(12):1719-1727.
  11. Gourgari EA, Mete M, Sampson ML, Harlan DM, Remaley AT, Rother KI: Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes. Diabetes care 2017, 40(7):e88-e89.
  12. Gourgari E, Spanakis E, Dobs AS: Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome. International journal of women's health 2016, 8:381-387.
  13. Bandettini WP, Karageorgiadis AS, Sinaii N, Rosing DR, Sachdev V, Schernthaner-Reiter MH, Gourgari E, Papadakis GZ, Keil MF, Lyssikatos C et al: Growth hormone and risk for cardiac tumors in Carney complex. Endocrine-related cancer 2016, 23(9):739-746.
  14. Magee MF, Gourgari E, Youssef GA, Nassar CM: mHealth Real-Time Blood Glucose Monitoring Facilitates Glycemic Management. Journal of diabetes science and technology 2017, 11(1):172-173.
  15. Gourgari E, Lodish M, Keil M, Sinaii N, Turkbey E, Lyssikatos C, Nesterova M, de la Luz Sierra M, Xekouki P, Khurana D et al: Bilateral Adrenal Hyperplasia as a Possible Mechanism for Hyperandrogenism in Women With Polycystic Ovary Syndrome. The Journal of clinical endocrinology and metabolism 2016, 101(9):3353-3360
  16. Gourgari E, Lodish M, Shamburek R, Keil M, Wesley R, Walter M, Sampson M, Bernstein S, Khurana D, Lyssikatos C et al: Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk. The Journal of clinical endocrinology and metabolism 2015, 100(11):4291-4298.
  17. Afshari A, Ardeshirpour Y, Lodish MB, Gourgari E, Sinaii N, Keil M, Belyavskaya E, Lyssikatos C, Chowdhry FA, Chernomordik V et al: Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome. The Journal of clinical endocrinology and metabolism 2015, 100(10):3928-3933.
  18. Faucz FR, Horvath AD, Azevedo MF, Levy I, Bak B, Wang Y, Xekouki P, Szarek E, Gourgari E, Manning AD et al: Is IGSF1 involved in human pituitary tumor formation? Endocrine-related cancer 2015, 22(1):47-54.
  19. Gourgari E, Lodish M, Keil M, Wesley R, Hill S, Xekouki P, Lyssikatos C, Belyavskaya E, De La Luz SM, Stratakis CA: Post-operative growth is different in various forms of pediatric Cushing's syndrome. Endocrine-related cancer 2014, 21(6):L27-31.
  20. Crocker MK, Gourgari E, Lodish M, Stratakis CA: Use of aromatase inhibitors in large cell calcifying sertoli cell tumors: effects on gynecomastia, growth velocity, and bone age. The Journal of clinical endocrinology and metabolism 2014, 99(12):E2673-2680.
  21. Gourgari E, Nella AA, Lodish M, Stratakis CA, Yanovski JA: Vitamin B12 deficiency in an adolescent girl with polycystic ovarian syndrome. European journal of obstetrics, gynecology, and reproductive biology 2014, 179:254.
  22. Lodish MB, Gourgari E, Sinaii N, Hill S, Libuit L, Mastroyannis S, Keil M, Batista DL, Stratakis CA: Skeletal maturation in children with Cushing syndrome is not consistently delayed: the role of corticotropin, obesity, and steroid hormones, and the effect of surgical cure. The Journal of pediatrics 2014, 164(4):801-806.
  23. London E, Rothenbuhler A, Lodish M, Gourgari E, Keil M, Lyssikatos C, de la Luz Sierra M, Patronas N, Nesterova M, Stratakis CA: Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications. The Journal of clinical endocrinology and metabolism 2014, 99(2):E303-310.
  24. Salpea P, Horvath A, London E, Faucz FR, Vetro A, Levy I, Gourgari E, Dauber A, Holm IA, Morrison PJ et al: Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. The Journal of clinical endocrinology and metabolism 2014, 99(1):E183-188.
  25. Xekouki P, Mastroyiannis SA, Avgeropoulos D, de la Luz Sierra M, Trivellin G, Gourgari EA, Lyssikatos C, Quezado M, Patronas N, Kanaka-Gantenbein C et al: Familial pituitary apoplexy as the only presentation of a novel AIP mutation. Endocrine-related cancer 2013, 20(5):L11-14.
  26. Azevedo MF, Horvath A, Bornstein ER, Almeida MQ, Xekouki P, Faucz FR, Gourgari E, Nadella K, Remmers EF, Quezado M et al: Cyclic AMP and c-KIT signaling in familial testicular germ cell tumor predisposition. The Journal of clinical endocrinology and metabolism 2013, 98(8):E1393-1400.
  27. Crutchfield CA, Olson MT, Gourgari E, Nesterova M, Stratakis CA, Yergey AL: Comprehensive analysis of LC/MS data using pseudocolor plots. Journal of the American Society for Mass Spectrometry 2013, 24(2):230-237.
  28. Gourgari E, Saloustros E, Stratakis CA: Large-cell calcifying Sertoli cell tumors of the testes in pediatrics. Current opinion in pediatrics 2012, 24(4):518-522.
  29. Avgerinos DV, Kyriakopoulos CE, Konstantinopoulou S, Gourgari E, Lioutas V: Post-traumatic splenic cysts treated with laparoscopy: two case reports. Cases journal 2009, 2:7976

Ratings and reviews

  • Explanations the care provider gave you about your problem or condition

  • Extent to which the care provider listened to you

  • Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

  • Care provider's efforts to include you in decisions about your care

  • Concern the care provider showed for your questions or worries

  • Likelihood of recommending this care provider to others

  • May 23, 2023

    Dr Gourgari was amazing- spent a lot of time getting to know us, our situation and coming up with a medical plan.

  • May 2, 2023

    She took her time in explaining things which I liked.

  • Apr 20, 2023

    We spend about anHour and a half with this provider, discussing the issues we were thereDiscuss with multiple ideas and possible treatment options. I have never had a physician spend so much time in and apt and be so thorough with her discussion.